Commonwealth Equity Services’s IGC Pharma IGC Stock Holding History

Commonwealth Equity Services’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.07K	Sell	33,348 -500	-1%	-$148	﹤0.01%	4406
2026 Q1	$8.9K	Buy	33,848 +500	+1%	+$139	﹤0.01%	4287
2025 Q4	$9.38K	Sell	33,348 -1,600	-5%	-$570	﹤0.01%	4265
2025 Q3	$15K	Hold	34,948	–	–	﹤0.01%	4216
2025 Q2	$11K	Buy	34,948 +348	+1%	+$105	﹤0.01%	4231
2025 Q1	$10K	Hold	34,600	–	–	﹤0.01%	4148
2024 Q4	$12K	Sell	34,600 -10,000	-22%	-$3.74K	﹤0.01%	4064
2024 Q3	$19K	Buy	44,600 +10,000	+29%	+$4.01K	﹤0.01%	3999
2024 Q2	$15K	Buy	+34,600	New	+$17.2K	﹤0.01%	3981
2023 Q4	–	Sell	-165,490	Closed	-$59K	–	3962
2023 Q3	$59K	Buy	165,490 +112,334	+211%	+$40.2K	﹤0.01%	3642
2023 Q2	$17K	Hold	53,156	–	–	﹤0.01%	3758
2023 Q1	$18K	Sell	53,156 -650	-1%	-$244	﹤0.01%	3681
2022 Q4	$17K	Sell	53,806 -150	-0.3%	-$61	﹤0.01%	3611
2022 Q3	$23K	Buy	53,956 +3,706	+7%	+$1.98K	﹤0.01%	3563
2022 Q2	$26K	Buy	+50,250	New	+$31.7K	﹤0.01%	3549

Other funds holding IGC

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Lawood & Co Williamsport, Pennsylvania $148M AUM

Commonwealth Equity Services's IGC Position: Q2 2026 in Review

Commonwealth Equity Services reduced its IGC Pharma (IGC) stake by 1.5% in Q2 2026, selling an estimated $148 and leaving 33,348 shares worth $9.07K. The position accounts for ﹤0.01% of the portfolio, ranked #4406.

Commonwealth Equity Services first reported a position in IGC in Q2 2022 and has held it in 15 quarters since. The position peaked at $59K in Q3 2023. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

Commonwealth Equity Services held 33,348 shares of IGC Pharma worth $9.07K as of Q2 2026.
Commonwealth Equity Services sold 500 IGC Pharma shares in Q2 2026, an estimated $148.
IGC Pharma made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4406 holding.
Commonwealth Equity Services first reported a position in IGC Pharma in Q2 2022 and has held it in 15 quarters since.
Commonwealth Equity Services's IGC Pharma position peaked at $59K in Q3 2023.
36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.